Stock-Market Research Dispatch — 2026-06-05

Auto-generated by daily research routine. Not a source; not ingest-pending material. Summary of what changed in the wiki today.

Top of mind

Cattle cycle thesis just received its sharpest confirmation yet. The USDA January 2026 inventory survey puts the US herd at 86.2 million head — the 75-year low, now with a specific number. More importantly: the DSCI drought index is at 202 (a record high), with 79% of the US cattle inventory in drought-affected regions, vs 41% at the 2012 prior peak. The Mexican feeder cattle border closure adds 1.2 million head/year (~5% of annual slaughter supply) on top of the structural cycle. Multiple independent sources converge on the same conclusion: meaningful supply relief is "not before 2028–2029." The chain from supply squeeze to live-cattle exposure (cattle-live-exposure-cow-etf-squeeze hypothesis) is maturing.

CEG still below the entry window. At $264.59 today, Constellation Energy remains below the $270–285 Calpine lockup floor established in ceg-calpine-lockup-entry-window. Two catalysts converge by June 30: the FERC RM26-4-000 large-load ruling and the Calpine lockup expiry. Yesterday's dispatch flagged this and it remains the highest-priority entry candidate. Analyst consensus is $367.12 = 38.7% upside.

MU down 7.7% today ($996 from $1,079). No thesis-specific news found — appears macro/rate-driven. The helium cliff closes June–July 2026 (SK Hynix buffer) and the helium-cliff-to-hbm-supply-crunch / skhynix-helium-section232-micron-hbm-window thesis remains intact. Q3 FY2026 earnings June 24 is the next fundamental gate. A -7.7% daily move on no thesis-specific news is noise, not signal — if anything, it modestly improves the entry for fresh positions.

INTC at $111.78 — VLSI gate this week. The VLSI conference (June 14–18) is the last fundamental checkpoint before exit. The June 3 autoresearch already confirmed 18A yield >60% rising 7-8%/month and an NVIDIA PAM-4 co-authored paper using Intel process — yield thesis confirmed. At $111.78, INTC remains above analyst consensus of $89.32. Exit discipline applies: if the VLSI presentation adds nothing materially beyond what's already public, the easy money is made.

SLB and HON now on the map. Six new entity pages filed today from the earnings-call backlog (April–May calls). SLB's data-center solutions business (+45% YoY, NVIDIA partnership, $1B run-rate target) is a non-obvious AI infrastructure pick — oilfield services companies' modular harsh-environment build expertise translating to data-center construction in difficult markets. HON explicitly flagged the liquid cooling TAM as a new market it's sizing. Both add evidence to the AI infrastructure buildout thesis without changing the picks-and-shovels hierarchy.

Strongest-conviction buys

Ranked shortlist from step 4c. Research output, not advice.

Watchlist

Undervalued candidates (today)

• CEG at $264.59 — below the $270–285 entry window for the third consecutive day. The thesis case: 38.7% upside to analyst consensus ($367.12), both a datable supply-overhang event (Calpine lockup June 30) and a regulatory catalyst (FERC large-load ruling end-June) converging in < 25 days. FERC CIR waiver (June 1) already resolved the 2031 TMI delay risk. No new contradictions in today's research.

• LNG at $241.07 — Cheniere is 20% below analyst consensus. The Iran/Hormuz LNG disruption thesis is reinforced by today's MacroVoices source (Michael Every — Hormuz shipping costs persisting, nitrogen supply via Iran disrupted). Q1 2026 record 187 cargoes and EBITDA guidance raised $500M — primary-source confirmation in the book. Graduate from hypothesis to active signal pending Q2 earnings confirmation.

• NOW at $103.30 — further below prior mark of $117.90. The agentic-AI seat-erosion thesis is intact and the consumption-pricing pivot is confirmed (primary-source: 50% non-seat-based Q1 2026). Price has deteriorated further, widening the thesis gap. No new contradictions in today's research.

• MP at $65.46 — down from $100.25 52w high. DOD backstop ($400M preferred equity + $110/kg floor + 100% off-take) makes economics independent of China reinstatement. HREE circuit commissioning on track Q2 2026 (confirmed by today's autoresearch). First US domestic Tb/Dy targeted H2 2026. Needham Buy/PT $81. The stock is down 35% from its high while the underlying thesis has gotten more concrete.

Updated theses

• cattle-cycle-beef-supply-squeeze — Major reinforcement today. USDA 86.2M head confirmed (75-year low with a number). DSCI 202 record drought (79% of herd vs 41% in 2012). Mexican feeder cattle border closure adds 1.2M head/year (~5% slaughter supply). Retail beef $9.64/lb (+13% YoY). Supply relief "not before 2028–2029." The thesis is maturing toward mechanism-grade. cattle-live-exposure-cow-etf-squeeze hypothesis strengthened — needs confirm on COW ETF mechanics.

• glp1-protein-demand-to-cheese-glut — Scale confirmed. FDA approved oral semaglutide (Wegovy oral, NVO) January 2026 — cold-chain barrier eliminated. Eli Lilly oral orforglipron expected Q2 2026. JPMorgan estimates $30–55B F&B revenue at risk by 2030–34 (the forced the chain's consumer-behavior leg onto a dollar scale). JPMorgan medtech: "no indication" of GLP-1 procedure volume impact through H1 2026 — only bariatric surgery (-46%) affected; orthopedics/cardiac/robotic surgery unaffected. Conviction bumped: low → low-medium.

• hormuz-nitrogen-supply-shock-to-cf-risk-premium — Updated with MacroVoices (Michael Every, Rabobank) on Iran/Hormuz shipping costs and nitrogen supply chain disruption. Independent non-earnings-call source corroborates CF CEO Bohn's "fundamental shift in global nitrogen risk-return framework." Two independent sources now.

• ferc-large-load-to-dc-gridscale-construction — Binary catalyst: FERC RM26-4-000 ruling end-of-June 2026. HON Q1 2026 earnings source adds: liquid cooling TAM explicitly flagged by management as new market to size. SLB Q1 2026 adds: oilfield services modular expertise pivoting to data-center construction (NVIDIA partnership, $1B run-rate target).

• slb-oilfield-pivot-to-dc-infrastructure — New mechanism filed today (extract-mechanisms Step 4a). SLB modular oilfield capabilities → AI DC infrastructure pull → data center solutions +45% YoY + NVIDIA partnership → $1B run-rate target by year-end 2026. Low-medium conviction; ticker SLB. A non-obvious AI infrastructure pick that diversifies away from the direct construction plays (PWR/FIX/GEV/VRT).

• ai-power-gap-to-ep-direct-supply-entry — XOM is absent from AI power supply deals. CVX-MSFT is the protagonist; XOM explicitly not participating as of Q1 2026 earnings. This is a real differentiation: the mechanism holds (E&P majors entering AI power supply), but it's concentrated in CVX (West Texas gas-to-power FID H2 2026) not sector-wide. The XOM entity page documents this contrast.

New entities filed today

6 entity pages created from the April–May earnings-call backlog:

• intuitive-surgical (ISRG) — procedures +16%, Ion +39%, da Vinci 5 adoption
• unh (UNH) — MCR 83.9%, GLP-1 Medicare "find path to yes"
• hon (HON) — Building Automation +8%, liquid cooling TAM flagged, Aerospace spin-off June 29
• slb (SLB) — Data Center Solutions +45%, NVIDIA partnership, Middle East force majeure $607M
• xom (XOM) — Golden Pass LNG Train 1 first LNG March 2026, absent from AI power deals
• deere (DE) — See & Spray 1M acres, tariff $1.2B headwind, large-ag weakness

Flagged for exit review

• INTC (all three mechanisms) — Stock $111.78, above consensus $89.32 (25% premium to analyst target). Paper ledger mark from June 4: −20.2% sector-excess vs SMH. VLSI Jun 14–18 is the last fundamental checkpoint before exit execution. Pre-VLSI yield data (18A >60%, rising 7-8%/mo) is already in the public domain; the official conference may confirm rather than surprise. If VLSI brings no incremental information, exit signal is clear.

Calibration logged

• None today. All new sources produced reinforcement (cattle cycle, GLP-1 scale, helium) rather than contradictions. The medtech-GLP-1 finding ("no indication" JPMorgan) is net positive — narrows the GLP-1 disruption risk to bariatric surgery specifically, not medtech broadly.

Paper ledger note

Step 4d was completed 2026-06-04 (not repeated today). Current state:

• 26 open positions (22 priced, 4 unpriced KRW/ADR/CBRS)
• Mean position +3.85% · vs sector −0.52% · hit rate 44% (as of 2026-06-04)
• Today's notable move: MU −7.7% ($996 from $1,079) on no thesis-specific news

What I looked at

• Sources promoted: 0 new today (all promotions done in prior session)
• Sources ingested (step 4 backlog): 17 sources (12 April–June earnings calls + autoresearches)
• Entity pages created: 6 (ISRG, UNH, HON, SLB, XOM, DE)
• Concept/mechanism pages updated: 2 (cattle-cycle-beef-supply-squeeze major update; glp1-protein-demand-to-cheese-glut additional evidence)
• Extract-mechanisms pass: complete (Step 4a). 1 new mechanism filed: slb-oilfield-pivot-to-dc-infrastructure (SLB oilfield services modular expertise → AI DC infrastructure, low-medium conviction, 3 confirmed steps, ticker: SLB). 1 new person entity: olivier-le-peuch (SLB CEO, 4 quotes). HON liquid cooling TAM did not qualify (no competitive-positioning quote for HON specifically). XOM absence updated Step 3 of ai-power-gap-to-ep-direct-supply-entry. Fed rate regime autoresearch reinforces P&C/private-credit hypotheses (not graduation-ready yet without earnings confirms).
• Valuation snapshots: INTC $111.78, LIN $507.45, CEG $264.59, CF $113.30, CCJ $114.02, MP $65.46, PWR $719.57, CAT $940.48, ARM $393.44, MU $996.00, LNG $241.07, BLK $1,022.56, CMI $678.10, NVDA $218.66, TSM $444.92, RSP $209.21, NOW $103.30
• Calibration events: 0
• New signals to emit: LNG → active (pending Q2 earnings confirm); CEG updated entry context